Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biosimilars
Biotech
Coherus scratches the Surface with $65M buy
Coherus is doubling down on its immuno-oncology pipeline with a $65 million deal to buy Surface Oncology.
Max Bayer
Jun 16, 2023 10:45am
Fresenius Kabi nabs smart infusion pump maker Ivenix for $240M
Mar 31, 2022 12:36pm
Henlius falls short of IPO goal but still rakes in $410M on HKEX
Sep 18, 2019 10:40am
Sorrento sues Soon-Shiong over cancer drug 'catch-and-kill'
Apr 3, 2019 6:37pm
Innovent buys Chinese rights to Incyte drugs for $40M upfront
Dec 17, 2018 9:23am
Momenta calls time on biosimilar R&D
Oct 2, 2018 8:56am
